Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2000
06/22/2000WO2000036110A2 Plant disease resistance genes
06/22/2000WO2000036109A1 Maize rad2/fen-1 orthologues and uses thereof
06/22/2000WO2000036108A2 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides
06/22/2000WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036104A1 Pancreatic polypeptide zsig66
06/22/2000WO2000036103A1 Cytokine receptor chain
06/22/2000WO2000036102A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/22/2000WO2000036101A2 An atp-binding cassette protein responsible for cytotoxin resistance
06/22/2000WO2000036100A1 Protein kinase targeting protein
06/22/2000WO2000036094A1 Bleaching enzymes and detergent compositions comprising them
06/22/2000WO2000036093A2 Intein-mediated cyclization of peptides
06/22/2000WO2000036092A2 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
06/22/2000WO2000036087A2 Nucleolus autoantigenic marker for systematic lupus erythematosus
06/22/2000WO2000036083A2 Pkc-interacting cousin of trx (picot) polypeptides, polynucleotides, and methods of making and using them
06/22/2000WO2000035955A1 Use of oestrogen receptor variants in anticancer therapy
06/22/2000WO2000035954A1 Human g protein coupled receptor
06/22/2000WO2000035953A1 Novel g protein-coupled receptor protein and dna thereof
06/22/2000WO2000035952A2 Compounds for control of eating, growth and body weight
06/22/2000WO2000035951A1 Natriuretic peptide fragments
06/22/2000WO2000035950A2 Reagents and methods useful for detecting diseases of the breast
06/22/2000WO2000035949A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
06/22/2000WO2000035947A1 Organic compounds
06/22/2000WO2000035943A1 Halovir, an antiviral marine natural product, and derivatives thereof
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation
06/22/2000WO2000035481A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
06/22/2000WO2000035480A2 Peptides useful in diagnosing and treating hiv-induced acquired immune deficiency disease
06/22/2000WO2000035479A1 Synthetic virus-like particles with heterologous epitopes
06/22/2000WO2000035478A1 Treatment of papillomavirus infections
06/22/2000WO2000035477A2 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
06/22/2000WO2000035474A1 Neurite derived growth factors for use in the treatment of muscular dystrophy
06/22/2000WO2000035471A1 Soluble haemopoietin receptor nr6 (clf-1) and uses thereof
06/22/2000WO2000035470A1 Human mad proteins and uses thereof
06/22/2000WO2000035430A2 Homer a new target of treating psychiatric disorders
06/22/2000WO2000035427A1 Methods for reducing the immunogenicity of proteins, tissues, or organs
06/22/2000WO2000035421A2 Integrative protein-dna cochleate formulations and methods for transforming cells
06/22/2000WO2000035407A2 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
06/22/2000WO2000035274A1 Olfactory receptor expression libraries and methods of making and using them
06/22/2000WO2000026362A3 Proteins of the stomatin family and their use as target proteins for pain therapy
06/22/2000WO2000024887A3 Method for biotechnological production of ligand binding, especially extracellular, fragments of receptor subunits, especially neuroreceptors and hormone receptors
06/22/2000WO2000023955A8 Virus-like particles for the induction of autoantibodies
06/22/2000WO2000017239A8 Purification of fibrinogen from fluids by precipitation and hydrophobic chromatography
06/22/2000WO2000014106A9 Novel bag proteins and nucleic acid molecules encoding them
06/22/2000WO2000012709A3 Phelix: a testis-specific protein expressed in cancer
06/22/2000WO2000012703A3 Protein transport-associated molecules
06/22/2000WO2000012544A3 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
06/22/2000WO2000012138A3 Cells expressing immunoregulatory molecules and uses therefor
06/22/2000WO2000012046A3 Pkdl nucleic acids, polypeptides, and diagnostic and therapeutic methods
06/22/2000WO2000011168A3 Genes that regulate hematopoietic blood forming stem cells and uses thereof
06/22/2000WO2000011165A9 ROLE OF HUMAN KIS (hKIS) AS AN INHIBITORY KINASE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27. COMPOSITIONS, METHODS AND USES THEREOF TO CONTROL CELL PROLIFERATION
06/22/2000WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins
06/22/2000WO2000011029A3 Novel anti-diabetic peptides
06/22/2000WO2000009695A3 Drug targets in candida albicans
06/22/2000WO2000009538A3 Canine growth hormone secretagogue receptor
06/22/2000WO2000009487A9 Near infrared chemiluminescent acridinium compounds and uses thereof
06/22/2000WO2000006759A3 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
06/22/2000WO2000006736A3 Nucleic acids and proteins from group b streptococcus
06/22/2000WO2000001712A9 Chemically modified proteins with a carbohydrate moiety
06/22/2000WO2000000158A9 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function
06/22/2000WO1999065937A3 Truncated apaf-1 and methods of use thereof
06/22/2000WO1999065928A8 Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
06/22/2000WO1999059615A9 Hybrid polypeptides with enhanced pharmacokinetic properties
06/22/2000WO1999057282A3 Pesticidal toxins and nucleotide sequences which encode these toxins
06/22/2000WO1999057150A3 Multivalent antibody constructs
06/22/2000WO1999054462A3 Bacterial ycfb polypeptide family
06/22/2000WO1999053068A3 Sucrose transporters from plants
06/22/2000CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/22/2000CA2407803A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/22/2000CA2406256A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/22/2000CA2405945A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/22/2000CA2405791A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/22/2000CA2362423A1 47 human secreted proteins
06/22/2000CA2355934A1 Intein mediated cyclization of peptides
06/22/2000CA2355901A1 Plant cell cycle genes and uses thereof
06/22/2000CA2355870A1 Reagents and methods useful for detecting diseases of the breast
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355287A1 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
06/22/2000CA2355276A1 Synthetic nucleic acid particle
06/22/2000CA2355270A1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
06/22/2000CA2355039A1 Pancreatic polypeptide zsig66
06/22/2000CA2354908A1 Bleaching enzymes and detergent compositions comprising them
06/22/2000CA2354539A1 A method for the high level expression of active lymphotoxin-.beta. receptor immunoglobulin chimeric proteins and their purification
06/22/2000CA2354527A1 Integrative protein-dna cochleate formulations and methods for transforming cells
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354451A1 Halovir, an antiviral marine natural product, and derivatives thereof
06/22/2000CA2354444A1 Synthetic virus-like particles with heterologous epitopes
06/22/2000CA2354433A1 Maize rad2/fen-1 orthologues and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354323A1 Homer a new target of treating psychiatric disorders
06/22/2000CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000CA2353997A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000CA2353866A1 Treatment of papillomavirus infections
06/22/2000CA2353818A1 Novel g protein-coupled receptor protein and dna thereof
06/22/2000CA2353560A1 Process for producing apelin
06/22/2000CA2348757A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/22/2000CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
1 ... 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 ... 2916